???global.info.a_carregar???
Ana Campar. Completed the PhD on the field of Idiopathic Inflammatory Myopathies (Myositis) in Ciências Médicas in 2024/02/16 by Universidade do Porto - Instituto de Ciências Biomédicas Abel Salazar. Has a Degree in Medicine in 2005/07/01 by Universidade de Coimbra - Faculdade de Medicina. Is Medical doctor in Centro Hospitalar Universitário do Porto EPE, Invited Assistant in Universidade do Porto - Instituto de Ciências Biomédicas Abel Salazar and Researcher in Universidade do Porto - Instituto de Investigação e Inovação em Saúde (i3S). Works in the area of Medical and Health Science - Clinical Medicine, with emphasis on Clinical Immunology. Published > 30 articles in peer-reviewed journals. Supervised 7 MSc dissertation(s). Has received 2 awards. Participates and/or participated as Co-Principal Investigator (Co-PI) in 7 project(s), Principal investigator (PI) in 3 project(s).
Read full resume ↓
Identification

Personal identification

Full name
Ana Cristina Cerveira Campar Almeida

Citation names

  • Campar, Ana
  • Campar A
  • A Campar
  • Ana Campar

Author identifiers

Ciência ID
B114-D73D-99FF
ORCID iD
0000-0002-3951-8961
Researcher Id
AAR-2266-2020
Scopus Author Id
36117705600

Email addresses

  • u09394@chporto.min-saude.pt (Professional)
  • anaccampar@hotmail.com (Personal)

Addresses

  • Largo Prof Abel Salazar, 4099-001, Porto, Porto, Portugal (Professional)

Knowledge fields

  • Medical and Health Sciences - Clinical Medicine - General and Internal Medicine

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Advanced (C1) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Education
Degree Classification
2018/01/01 - 2024/02/16
Concluded
 Ciências Médicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Glycans as novel immunomodulators in Idiopathic Inflammatory Myopathies" (THESIS/DISSERTATION)
2012/04/09 - 2021/05/03
Concluded
 Graduated Assistant (Outros)
Centro Hospitalar Universitário do Porto EPE, Portugal
2007/01/01 - 2011/12/31
Concluded
 Specialty in Internal Medicine (Título de especialista)
Centro Hospitalar Universitário do Porto EPE, Portugal
 19,6 valores
2009/10/01 - 2010/04/01
Concluded
 Rheumatology and Systemic Autoimmune Diseases fellowship (Outros)
University College London Centre for Rheumatology, United Kingdom
1999/09/01 - 2005/07/01
Concluded
 Degree in Medicine (Licenciatura)
Universidade de Coimbra Faculdade de Medicina, Portugal
 16 valores
Affiliation

Science

Category
Host institution 		Employer
2018/01/01 - Current Researcher (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Teaching in Higher Education

Category
Host institution 		Employer
2008/09/01 - Current Invited Assistant (University Teacher) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Others

Category
Host institution 		Employer
2007/01/01 - Current Medical doctor Centro Hospitalar Universitário do Porto EPE, Portugal
Centro Hospitalar Universitário do Porto EPE, Portugal
Projects

Contract

Designation Funders
2023 - Current A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis (VALOR)
2022-500367-12-00
Principal investigator
Centro Hospitalar Universitário do Porto EPE, Portugal
Ongoing
2023 - Current A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy (ALKIVIA)
ARGX-113-2007
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário do Porto EPE, Portugal
Ongoing
2017 - 2020 EXCEED
2015-004477-32
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário do Porto EPE, Portugal
Concluded
2014 - 2019 PRECISESADS
115565
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário do Porto EPE, Portugal
Concluded
2013 - 2017 BIO-SEQUETIA
2011-002894-48
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário do Porto EPE, Portugal
Concluded
2011 - 2016 Belimumab Assessment of Safety in SLE (BASE)
2011-005667-25
Principal investigator
Centro Hospitalar Universitário do Porto EPE, Portugal
Concluded
2012 - 2014 BIOLUPUS
07-RNP-083
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário do Porto EPE, Portugal
2010 - 2012 SWITCH-RA
2010-023880-17
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário do Porto EPE, Portugal

Other

Designation Funders
2020 - Current Integration of UIC's cohoort of Idiopathic Inflammatory Myopathies in the european myositis registry (Euromyositís registry)
nº 170-20 (133-DEFI/135-CE)
Principal investigator
Centro Hospitalar Universitário do Porto EPE, Portugal
Ongoing
2018/01/01 - 2024/02/16 Glycans as novel immunomodulators in Idiopathic Inflammatory Myopathies.
ND
NA
PhD Student Fellow
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Universidade do Porto, Portugal
Sociedade Portuguesa de Medicina Interna - Núcleo de Estudos de Doenças Autoimunes
Ongoing
2009 - 2012 Lupus and its compensation in an effected related by T cell regulation
NA
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário do Porto EPE, Portugal
Concluded
Outputs

Publications

Conference abstract
  1. A Campar; Ana Sá; Barbara Oliveira; António Marinho. "Efficacy of JAK Inhibitors in Idiopathic Inflammatory Myopathies (other Than Dermatomyositis)". Paper presented in ACR Convergence 2022, 2022.
    Published
  2. Campar, Ana; Vasconcelos, Carlos. "Performance of EULAR/ACR Classification Criteria for Idiopathic Inflammatory Myopathies in a Real-life Cohort of Adult Patients". Paper presented in 2019 ACR/ARP Annual Meeting, 2019.
    Published
  3. Campar, Ana; Vasconcelos, Carlos. "Damage and Comorbidities in a Cohort of Patients with Idiopathic Inflammatory Myopathy". Paper presented in 2019 ACR/ARP Annual Meeting, 2019.
    Published
Journal article
  1. Casares-Marfil, Desiré; Martínez-Bueno, Manuel; Borghi, Maria Orietta; Pons-Estel, Guillermo; Reales, Guillermo; Zuo, Yu; Espinosa, Gerard; et al. "A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome". Arthritis & Rheumatology 76 11 (2024): 1623-1634. https://doi.org/10.1002/art.42947.
    Published • 10.1002/art.42947
  2. Castellini-Pérez, Olivia; Povedano, Elena; Barturen, Guillermo; Martínez-Bueno, Manuel; Iakovliev, Andrii; Kerick, Martin; López-Domínguez, Raúl; et al. "Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants". npj Genomic Medicine 9 1 (2024): https://doi.org/10.1038/s41525-024-00420-0.
    Published • 10.1038/s41525-024-00420-0
  3. Parodis, Ioannis; Lindblom, Julius; Barturen, Guillermo; Ortega-Castro, Rafaela; Cervera, Ricard; Pers, Jacques-Olivier; Genre, Fernanda; et al. "Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort". Annals of the Rheumatic Diseases 83 7 (2024): 889-900. https://doi.org/10.1136/ard-2023-224795.
    Published • 10.1136/ard-2023-224795
  4. Parodis, Ioannis; Lindblom, Julius; Toro-Domínguez, Daniel; Beretta, Lorenzo; Borghi, Maria O.; Castillo, Jessica; Carnero-Montoro, Elena; et al. "Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis". Kidney International Reports 9 6 (2024): 1817-1835. https://doi.org/10.1016/j.ekir.2024.03.014.
    Published • 10.1016/j.ekir.2024.03.014
  5. Bettacchioli, Eléonore; Saraux, Alain; Tison, Alice; Cornec, Divi; Dueymes, Maryvonne; Foulquier, Nathan; Hillion, Sophie; et al. "Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation". Arthritis & Rheumatology 76 5 (2024): 751-762. https://doi.org/10.1002/art.42789.
    Published • 10.1002/art.42789
  6. Sofia Moura de Azevedo; Rita Carrilho Pichel; Egídio Freitas; Ana Campar; António Marinho; Teresa Mendonça. "Orthostatic hypotension as an unusual presentation of spinal calcium pyrophosphate deposition disease: case report and review of literature". Romanian Journal of Internal Medicine 0 0 (2023): http://dx.doi.org/10.2478/rjim-2023-0021.
    10.2478/rjim-2023-0021
  7. Campar, Ana; Alves, Inês; da Silva, Ana Martins; Farinha, Fátima; Vasconcelos, Carlos. "Idiopathic inflammatory myopathies – The burden of disease: Cohort analysis focusing on damage and comorbidities". Autoimmunity Reviews (2023): 103455. http://dx.doi.org/10.1016/j.autrev.2023.103455.
    In press • 10.1016/j.autrev.2023.103455
  8. Araújo Correia, João; Crespo, Jorge; Alves, Glória; Salvador, Fernando; Matos-Costa, João; Alves, José Delgado; Fortuna, Jorge; et al. "Biologic therapy in large and small vessels vasculitis, and Behçet’s disease: Evidence- and practice-based guidance". Autoimmunity Reviews 22 8 (2023): 103362. http://dx.doi.org/10.1016/j.autrev.2023.103362.
    Published • 10.1016/j.autrev.2023.103362
  9. Campar A; Alves I; Santos-Pereira B; Nogueira R; Pinto MM; Vasconcelos C; Pinho SS. "Muscle glycome in idiopathic inflammatory myopathies: Impact in IL-6 production and disease prognosis.". iScience (2023): https://europepmc.org/articles/PMC10316658.
    10.1016/j.isci.2023.107172
  10. Marinho, António; Delgado Alves, José; Fortuna, Jorge; Faria, Raquel; Almeida, Isabel; Alves, Glória; Araújo Correia, João; et al. "Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren’s syndrome: evidence- and practice-based guidance". Frontiers in Immunology 14 (2023): http://dx.doi.org/10.3389/fimmu.2023.1117699.
    10.3389/fimmu.2023.1117699
  11. Inês Alves; Beatriz Santos-Pereira; Noelia de la Cruz; Ana Campar; Vanda Pinto; Pedro M. Rodrigues; Marco Araújo; et al. "Host-derived mannose glycans trigger a pathogenic ¿d T cell/IL-17a axis in autoimmunity". Science Translational Medicine (2023): https://doi.org/10.1126/scitranslmed.abo1930.
    10.1126/scitranslmed.abo1930
  12. Foulquier, Nathan; Le Dantec, Christelle; Bettacchioli, Eleonore; Jamin, Christophe; Beretta, Lorenzo; Vigone, Barbara; Pers, Jacques-Olivier; et al. "Machine learning identifies a common signature for anti-SSA/Ro60 antibody expression across autoimmune diseases". Arthritis & Rheumatology (2022): http://dx.doi.org/10.1002/art.42243.
    10.1002/art.42243
  13. Moura, Joao; Duarte, Sara; Sardoeira, Ana; Neves-Maia, Joao; Damasio, Joana; Taipa, Ricardo; Carneiro, Paula; et al. "Anti-NMDAr Encephalitis and COVID-19 in a Patient With Systemic pANCA-Vasculitis and Recurrent Varicella Zoster Infection". The Neurohospitalist (2022): https://publons.com/publon/49863787/.
    10.1177/19418744211063709
  14. Campar, Ana; Sa, Ana; Oliveira, Barbara; Marinho, Antonio. "Efficacy of JAK Inhibitors in Idiopathic Inflammatory Myopathies (other Than Dermatomyositis)". Arthritis & Rheumatology (2022): https://publons.com/wos-op/publon/57407363/.
  15. Alves, Inês; Santos-Pereira, Beatriz; Dalebout, Hans; Santos, Sofia; Vicente, Manuel M.; Campar, Ana; Thepaut, Michel; et al. "Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus Erythematosus". Arthritis & Rheumatology 73 11 (2021): 2069-2077. http://dx.doi.org/10.1002/art.41768.
    10.1002/art.41768
  16. Soret, Perrine; Le Dantec, Christelle; Desvaux, Emiko; Foulquier, Nathan; Chassagnol, Bastien; Hubert, Sandra; Jamin, Christophe; et al. "A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome". Nat Commun (2021):
    Published • 10.1038/s41467-021-23472-7
  17. Kerick, Martin; González-Serna, David; Carnero-Montoro, Elena; Teruel, Maria; Acosta-Herrera, Marialbert; Makowska, Zuzanna; Buttgereit, Anne; et al. "Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology". Arthritis & Rheumatology 73 7 (2021): 1288-1300. http://dx.doi.org/10.1002/art.41657.
    10.1002/art.41657
  18. Serpa Pinto, Luísa; Xavier Pires, Sara; Carvalheiras, Graziela; Campar, Ana; Marinho, António; Farinha, Fátima; Vasconcelos, Carlos; Araújo Correia, João. "Biologics Drugs in Behçet’s Disease: A Single Centre Experience". (2021): https://revista.spmi.pt/index.php/rpmi/article/view/267.
    10.24950/rspmi.o.13.4.2021
  19. Alves, Ines; Santos-Pereira, Beatriz; Dalebout, Hans; Santos, Sofia; Vicente, Manuel M.; Campar, Ana; Thepaut, Michel; et al. "Protein mannosylation as a diagnostic and prognostic biomarker of lupus nephritis: An unusual glycan-neoepitope in systemic lupus erythematosus". Glycobiology (2021): https://publons.com/publon/45924639/.
    10.1002/ART.41768
  20. Alves, Ines; Vicente, Manuel M.; Dias, Ana M.; Gaifem, Joana; Rodrigues, Claudia; Campar, Ana; Pinho, Salome S.. "The Role of Glycosylation in Inflammatory Diseases". Advances in Experimental Medicine and Biology (2021): https://publons.com/publon/50548239/.
    10.1007/978-3-030-70115-4_13
  21. Barturen, Guillermo; Babaei, Sepideh; Catala-Moll, Francesc; Martinez-Bueno, Manuel; Makowska, Zuzanna; Martorell-Marugan, Jordi; Carmona-Saez, Pedro; et al. "Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases". Arthritis & Rheumatology (2021): https://publons.com/publon/37444868/.
    10.1002/ART.41610
  22. Serpa Pinto, Luisa; Lamas, Nuno Jorge; Campar, Ana; Ferreira, Alvaro; Cruz, Ana Rita. "Immunoglobulin G4 Related-Disease: A Rare Presentation With Secondary Hypereosinophilic Syndrome and Eosinophilic Ascites". Journal of Medical Cases 12 3 (2021): 107-111. https://doi.org/10.14740/jmc3634.
    Published • 10.14740/jmc3634
  23. Thiagarajan, Divya; Oparina, Nina; Lundström, Susanna; Zubarev, Roman; Sun, Jitong; Beretta, Lorenzo; Vigone, Barbara; et al. "IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases". Scientific Reports 10 1 (2020): http://dx.doi.org/10.1038/s41598-020-66981-z.
    10.1038/s41598-020-66981-z
  24. Alves, Ines; Santos-Pereira, Beatriz; Dalebout, Hans; Vicente, Manuel; Campar, Ana; Santos, Sofia; Thepaut, Michel; et al. "An unusual glycan-neoepitope with diagnostic and prognostic value in Systemic Lupus Erythematosus". Glycobiology (2020): https://publons.com/publon/45350146/.
  25. Pinheiro, Maria Guiomar; Costa, Ana Rita; Campar, Ana; Mendonça, Teresa; Guiomar Pinheiro; Ana Rita Costa; Ana Campar; Teresa Mendonça. "Effectiveness of Tocilizumab in the Treatment of Fasciitis with Eosinophilia: Two Case Reports". European Journal of Case Reports in Internal Medicine (2020): http://hdl.handle.net/10400.16/2598.
    10.12890/2020_001485
  26. Alves, I.; Pinto, V.; Santos-Pereira, B.; Campar, A.; Vizcaino, J. R.; Carneiro, F.; Vasconcelos, C.; Marinho, A.; Pinho, S.. "CHANGES IN CELLULAR GLYCOSYLATION AS A KEY FACTOR IN THE IMMUNOPATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases (2020): https://publons.com/publon/47396932/.
    10.1136/ANNRHEUMDIS-2020-EULAR.1231
  27. Furtado, I.; Pinheiro, G.; Campar, A.; Mendonça, T.. "Association of severe and therapy-refractory systemic lupus erythematosus and neuromyelitis optica: A management challenge". BMJ Case Reports 2018 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85048129787&partnerID=MN8TOARS.
    10.1136/bcr-2017-222139
  28. Pereira, Marcia S.; Alves, Ines; Vicente, Manuel; Campar, Ana; Silva, Mariana C.; Padrao, Nuno A.; Pinto, Vanda; et al. "Glycans as Key Checkpoints of T Cell Activity and Function". Frontiers in Immunology (2018): https://publons.com/publon/17482182/.
    10.3389/FIMMU.2018.02754
  29. Braga, J.; Campar, A.. "Biological causes of depression in systemic lupus erythematosus,Causas biológicas de depressão em doentes com lúpus eritematoso sistémico: Um estudo de revisão". Acta Reumatologica Portuguesa 2014 3 (2014): 218-226. http://www.scopus.com/inward/record.url?eid=2-s2.0-84922073354&partnerID=MN8TOARS.
  30. Campar, A.; Farinha, F.; Vasconcelos, C.; Campar, Ana; Farinha, Fatima; Vasconcelos, Carlos. "Refractory disease in Systemic Lupus Erythematosus". Autoimmunity Reviews 10 11 (2011): 685-692. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052261104&partnerID=MN8TOARS.
    10.1016/j.autrev.2011.04.027
  31. Campar, Ana; Isenberg, David A.. "Life-Threatening Complications of Biological Therapies". Autoimmune Diseases: Acute and Complex Situations (2011): https://publons.com/publon/32612574/.
    10.1007/978-0-85729-358-9_23
  32. Campar, A.; Isenberg, D.A.; Campar, Ana; Isenberg, David A.. "Primary Sjögren's syndrome activity and damage indices comparison". European Journal of Clinical Investigation 40 7 (2010): 636-644. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953522667&partnerID=MN8TOARS.
    10.1111/j.1365-2362.2010.02303.x
  33. Campar, Ana; Isenberg, David A.. "SJOGREN'S SYNDROME ACTIVITY AND DAMAGE INDICES COMPARISON". Rheumatology (2010): https://publons.com/publon/32612577/.
    10.1093/RHEUMATOLOGY/KEQ727
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2023/05 Diagnostic approach of Idiopathic Inflammatory Myopathies Global Summit of Internal Medicine
European Federation of Internal Medicine (Mexico)
2022 Efficacy of JAK Inhibitors in Idiopathic Inflammatory Myopathies (other than Dermatomyositis). ACR Convergence 2022
American College of Rheumatology (United States)
2019 Performance of EULAR/ACR ClassificationCriteria for Idiopathic Inflammatory Myopathies in a Real-life Cohort of Adult Patients. 2019 ACR/ARP Annual Meeting
American College of Rheumatology (United States)
2019 Damage and Comorbidities in a Cohort of Patients with Idiopathic Inflammatory Myopathy 2019 ACR/ARP Annual Meeting
American College of Rheumatology (United States)
2018/05 Glycans as new immunomodulators in Idiopathic Inflammatory Myopathies. 11th International Congress on Autoimmunity
Kenes group (Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2020/06/01 - 2021/07/11 Treatment with biological drugs in Idiopathic Inflammatory Myopathies
Supervisor of Catarina Veiga
 Medicina (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020/03/01 - 2021/07/11 Predictors of poor prognosis in idiopathic inflammatory myopathies.
Supervisor of Carla Rafaela de Oliveira Ferreira
 Medicina (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017 - 2017 Therapeutic effect of tobacco consumption in Behçet's disease. Role of nicotine as an alternative to smoking.
Supervisor
 Medicina (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2016 Specific Cardiovascular Risk Factors for Systemic Lupus Erythematosus.
Supervisor
 Medicina (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2014 Biological causes of depression in patients with systemic lupus erythematosus: a review study.
Supervisor
 Medicina (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2014 The role of nutrition in autoimmune diseases.
Supervisor
 Medicina (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2012 - 2013 Hydroxychloroquine: a new perspective in Systemic Lupus Erythematosus
Supervisor of André Costa
 Medicina (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Committee member

Activity description
Role 		Institution / Organization
2022/06 - Current Member of the national secretariat of the autoimmune diseases study group of Portuguese Internal Medicine Society.
Other
 Sociedade Portuguesa de Medicina Interna - Núcleo de Estudos de Doenças Autoimunes, Portugal

Evaluation committee

Activity description
Role 		Institution / Organization Funding entity
2015 - 2016 Member of the Scientific Committee appointed by the National Medical Association to prepare the NOC (Clinical Guidance Standard) on Fibromyalgia
Specialist
 Direcção-Geral da Saúde, Portugal

Journal scientific committee

Journal title (ISSN) Publisher
2023/07 - Current Frontiers in Immunology (1664-3224)
Distinctions

Award

2021 Pfizer Clinical Research Award
Pfizer Portugal, Portugal
2018 Basic Research Grant in Immunology
Sociedade Portuguesa de Medicina Interna - Núcleo de Estudos de Doenças Autoimunes, Portugal